• Michael Harsh, former CTO of GE Healthcare

    Michael Harsh is a co-founder and Chief Product Officer of Terapede Systems, a digital X-ray startup that focuses on developing an ultra-high resolution medical flat panel X-ray detector. He co-founded Terapede in 2015. Prior to Terapede, Mr. Harsh had a 36-year career with General Electric (GE). He held numerous positions within GE and served as Vice President and Chief Technology Officer of GE Healthcare, an $18 billion division of GE, where he led its global science and technology organization and research and development teams in diagnostics, healthcare IT and life sciences. In 2004, Mike was named Global Technology Leader – Imaging Technologies at the GE Global Research Center, where he led the research for imaging technologies across the company as well as the research associated with computer visualization and superconducting systems. Additionally, Mr. Harsh is a member of the boards of directors of, Compute Health (NYSE: CPUH-UN), Endra Life Sciences (NASDAQ: NDRA), Imagion Biosystems (IBX.AX), and EmOpti as well as being a member the Radiological Society of North America ("RSNA"), Research & Education Foundation Board of Trustees. He had previously served as a director for FloDesign Sonics until its acquisition by MilliporeSigma, a division of the Merck Group. He is also a McKinsey Senior Advisor and a consultant in the medical device industry. Mr. Harsh is a graduate of Marquette University, where he earned a bachelor’s degree in Electrical Engineering. He holds numerous U.S. patents in the field of medical imaging and instrumentation. In 2008, Mr. Harsh was elected to the American Institute for Medical and Biological Engineering College of Fellows for his significant contributions to the medical and biological engineering field.

  • Gene Saragnese

    Gene Saragnese joined MaxQ Technology Ltd. in January 2016, as its Chairman & Chief Executive Officer. MaxQ is a company founded in deep learning and computer vision.  MaxQ delivers patient-specific lifesaving diagnostic information directly to the physician at the patient’s bedside.  In early 2020, he moved into the role of Vice Chairman at MaxQ.

    Mr. Saragnese also served as the Chairman of the Board of Mirada Medical, a Healthcare SW company and Independent director on the Insightec board. Prior to joining MaxQ, Gene Saragnese served as the Philips Healthcare CEO of Philips Imaging Systems from April 2009 until May 2015. 

    As the Executive Vice President and CEO of Philips Imaging Systems, he led the company's Imaging Systems business, a $7.5B enterprise, encompassing Advanced Diagnostic Imaging (Computed Tomography, Magnetic Resonance Imaging, and Molecular Imaging); Diagnostic X-Ray; Interventional and Ultrasound. He also directed Integrated Clinical Solutions which took a disease-focused approach to health care, and included the radiation and interventional oncology business. He was responsible for 10,000 employees at sites in the United States, India, the Netherlands, Germany, Israel, China and Brazil.

    Before joining Philips, Mr. Saragnese served as GE Healthcare’s Vice President and General Manager of Molecular Resonance Imaging and Computed Tomography. In this capacity, he led a multi-billion-dollar business group, including Computed Tomography, Positron Emission Tomography (PET), Nuclear Imaging, PET Radiopharma, Preclinical Imaging and Image Post Processing. Prior to that, he served as Chief Technology Officer, Vice President of Global Technology for GE Healthcare. In this role, Mr. Saragnese led Global Product Development Engineering and Component Operations around the world, including Corporate Research sites in New York, China, India and Germany. He has also served as General Manager Global Sourcing leading a global $6B procurement operation, General Manager for GE Medical Systems’ Global MRI business and the leader for GE Medical Systems’ Global MRI Engineering organization.

    Prior to his career in health care, Mr. Saragnese held management roles with GE, RCA, Martin Marietta and Lockheed Martin in the aerospace industry. He is a graduate of Rutgers College of Engineering in New Jersey.

  • Richard Ehman, Professor of Radiology at Mayo Clinic and former Chair of Radiology Section at NIH

    Richard L. Ehman, MD, is Professor of Radiology and Blanche and Richard Erlanger Professor of Medical Research at the Mayo Clinic. His research program is focused on developing advanced imaging technologies. He holds more than 100 US and foreign patents for his inventions, many widely used in medical care. He has served as chair of the Radiology and Nuclear Medicine Study Section of the NIH and on the National Advisory Council of NIBIB. He has been awarded Gold Medals by the International Society for Magnetic Resonance in Medicine, the Society of Advanced Body Imaging, and the Radiological Society of North America. He is a Fellow of the National Academy of Inventors and is an elected member of the National Academy of Medicine. He has served as president of the ISMRM, the Academy of Radiology Research, and the Society for Advanced Body Imaging and the Radiological Society of North America.